Product Name | MF | CAS | Details |
---|
Dimethyl({[2-(5-methylfuran-2-yl)-1,3-thiazol-4-yl]methyl})amine | C11H14N2OS | 1197527-61-9 | Details |
2-Methyl-2-(4-oxocyclohexyl)propanoic acid | C10H16O3 | 156042-34-1 | Details |
2-amino-4-bromo-6-chlorophenol | C6H5BrClNO | 855836-14-5 | Details |
Neisseria Gonorrhoeae Mouse Monoclonal Antibody | Details |
Diethyl(methylsulfonylmethyl)phosphonate | C6H15O5PS | 40137-11-9 | Details |
2-({[(tert-Butoxy)carbonyl]amino}methyl)furan-3-carboxylic acid | C11H15NO5 | 1256156-45-2 | Details |
H-Thr-Glu-OH | C9H16N2O6 | 54532-73-9 | Details |
4-(1-Hydroxy-1H-1,2,3-benzotriazole-6-sulfonamido)benzoic acid | C13H10N4O5S | 749906-99-8 | Details |
L-Histidine amide dihydrochloride | C6H12Cl2N4O | 71666-95-0 | Details |
L-Serine 7-amido-4-methylcoumarin hydrochloride | C13H15ClN2O4 | 115918-60-0 | Details |
2-methyl-1-(4-(isopropyl)phenyl)-2-(1,2,4-triazolyl)propan-1-one | C15H19N3O | 1020252-48-5 | Details |
FKBP2 protein | Details |
(4-Ethoxyoxan-4-yl)methanol | C8H16O3 | 1879334-33-4 | Details |
2-O-Tetradecylglycerol | C17H36O3 | 1561-06-4 | Details |
3,5-Dibromo-2-methoxythiophene | C5H4Br2OS | 77133-30-3 | Details |
5-Fluoro-4-hydrazinylpyrimidine | C4H5FN4 | 1092307-06-6 | Details |
Fasnall benzenesulfonate salt | C19H22N4S | 929978-58-5 | Details |
2-indol-3-yl-2-oxo-N-(4-(trifluoromethoxy)phenyl)ethanamide | C17H11F3N2O3 | 852367-70-5 | Details |
GABRB2 antibody | Details |
1-Methyl-1-(propan-2-yl)guanidine hydrochloride | C5H14ClN3 | 1258640-00-4 | Details |
N-Ethyl-N-(morpholin-2-ylmethyl)pyridazin-3-amine | C11H18N4O | 1423035-12-4 | Details |
7-Chloro-8-fluoroimidazo[1,2-a]pyridine | C7H4ClFN2 | 628691-87-2 | Details |
Metomidate HCL | Details |
Shizukanolide H | C17H20O5 | 1136932-34-7 | Details |
(2-Methyloxan-4-yl)methanamine hydrochloride | C7H16ClNO | 1427380-34-4 | Details |
TMEM107 Blocking Peptide | Details |
3-(3-Methoxy-4-methylphenyl)propanoic acid | C11H14O3 | 67199-60-4 | Details |
HTATSF1 antibody | Details |
8-({[(tert-Butoxy)carbonyl]amino}methyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid | C17H23NO4 | 165949-89-3 | Details |
Methyl 6-chloro-1-methyl-1H-1,3-benzodiazole-2-carboxylate | C10H9ClN2O2 | 1565595-24-5 | Details |
2-Hydroxy-5-methylacetophenone | C9H10O2 | 1450-72-2 | Details |
ABCF3 antibody | Details |
5-Fluoro-2,3-dihydro-1-benzofuran-2-carboxylic acid | C9H7FO3 | 89197-63-7 | Details |
Monosulfuron ester | C14H14N4O5S | 175076-90-1 | Details |
1-(5-tert-Butylpyridin-2-yl)-2-phenylethan-1-one | C17H19NO | 2287300-84-7 | Details |
2,3-Difluoro-5-methylbenzoic acid | C8H6F2O2 | 1003709-96-3 | Details |
4-(3,4-Dihydro-2H-1,5-benzodioxepine-7-sulfonamido)butanoic acid | C13H17NO6S | 781626-94-6 | Details |
3-Methyl-1-propyl-1H-pyrazole-5-carbaldehyde | C8H12N2O | 1351386-04-3 | Details |
3-Cyanopropionaldehydedimethylacetal | C6H11NO2 | 14618-78-1 | Details |
4-Methoxyphenyl 4-O-(3,6-di-O-benzyl-2-deoxy-2-phthalimido-b-D-glucopyranosyl)-3-O-benzyl-2-deoxy-6-O-(4-methoxybenzyl)-2-phthalimid o-b-D-glucopyranoside | C64H60N2O15 | Details |
H-WMDF-NH2 | Details |
(2-Cyclopropylpropyl)hydrazine hydrochloride | 2253639-98-2 | Details |
Cephalexin hydrochloride | C16H18ClN3O4S | 59695-59-9 | Details |
rac-(1R,3S)-2,2-Dimethyl-3-phenoxycyclobutan-1-ol | C12H16O2 | 1807896-10-1 | Details |
2-(Bromomethyl)-4-methoxy-1-(trifluoromethyl)benzene | C9H8BrF3O | 1261682-10-3 | Details |
RASH antibody | Details |
3-cyclopentyl-2-methylpropanoic acid | C9H16O2 | 264258-60-8 | Details |
6-(3-Bromophenyl)-5-methoxypyrimidin-4-amine | C11H10BrN3O | 1549248-83-0 | Details |
2',3',5',6'-Tetrahydrospiro[indoline-3,4'-pyran]-2-one | C12H13NO2 | 304876-29-7 | Details |
SR9011 | C23H31ClN4O3S | 1379686-29-9 | Details |
1-(2-Methoxypyridin-4-yl)ethanone | C8H9NO2 | 764708-20-5 | Details |
4-Fluoro-2-(trifluoromethyl)benzene-1-carboximidamide hydrochloride | C8H7ClF4N2 | 1187927-62-3 | Details |
N-(4-Nitrobenzoyl)-beta-alanine | C10H10N2O5 | 59642-21-6 | Details |
Ap-1/nf-IB activation inhibitor 1 | C13H11F3N4O4 | 188936-12-1 | Details |
2-(4-Ethylphenyl)morpholine | C12H17NO | 1017417-84-3 | Details |
2-[2-(Dicyclohexylphosphino)phenyl]-1-methyl-1H-indol | C27H34NP | 1067883-58-2 | Details |
3-ethylindolin-2-one | C10H11NO | 15379-45-0 | Details |
3-Amino-6-(trifluoromethyl)pyridine-2-carboxylic acid | C7H5F3N2O2 | 1260666-45-2 | Details |
(2R)-2-(Methylamino)butanoic acid hydrochloride | C5H12ClNO2 | 2377004-22-1 | Details |
2-Amino-2-(oxan-4-yl)ethan-1-ol hydrochloride | C7H16ClNO2 | 1375472-26-6 | Details |
LYVE1 protein | Details |
Hexahydro-[1,3]dioxolo[4,5-c]pyrrole-2,4-dione | C5H5NO4 | 2225141-92-2 | Details |
2-(4-Bromobenzenesulfonamido)benzoic acid | C13H10BrNO4S | 51012-29-4 | Details |
Gurmarin | 138464-10-5 | Details |
3-(3-Nitrophenyl)-1-phenyl-1H-pyrazole-4-carboxylic acid | C16H11N3O4 | 376358-93-9 | Details |
4-Bromo-3-chloro-2-fluorobenzyl alcohol | C7H5BrClFO | 1702154-18-4 | Details |
1-Ethynylcyclopropane-1-sulfonyl fluoride | C5H5FO2S | 2137823-37-9 | Details |
Anti-Perilipin 2 (mouse N-terminus) guinea pig Polyclonal | Details |
rac-Methyl (1R,3S,5S,8R)-8-hydroxybicyclo[3.2.1]octane-3-carboxylate | C10H16O3 | 2375248-91-0 | Details |
1-[(Pyrrolidin-3-yl)methyl]-1H-1,2,3-triazole | C7H12N4 | 1547757-37-8 | Details |
2-(Pyrrolidin-1-yl)ethanethioamide | C6H12N2S | 760898-91-7 | Details |
(3R,4Z)-4-Ethylidenetetrahydro-5-oxo-3-furanacetaldehyde | C8H10O3 | 144128-26-7 | Details |
C12ORF42 Blocking Peptide | Details |
N-[4-(2-Chloroacetyl)phenyl]-3-methylbutanamide | C13H16ClNO2 | 565171-58-6 | Details |
1,4-Dioxaspiro[4.4]nonan-2-ylmethanamine | C8H15NO2 | 4745-17-9 | Details |
Methyl 5-(bromomethyl)-2-nitrobenzoate | C9H8BrNO4 | 88071-91-4 | Details |
5-(2-Chlorophenoxymethyl)-4-cyclopropyl-4H-1,2,4-triazole-3-thiol | C12H12ClN3OS | 851169-44-3 | Details |
5-Methyl-5-(pyrazin-2-yl)imidazolidine-2,4-dione | C8H8N4O2 | 1198166-86-7 | Details |
Methyl 3-[(trifluoromethyl)sulfanyl]propanoate | C5H7F3O2S | 29271-31-6 | Details |
1-(2,2-Diethoxyethyl)-4-phenylpiperazine | C16H26N2O2 | 250282-63-4 | Details |
PBB 154 | C12H4Br6 | 36402-15-0 | Details |
N1,N2-Bis[2-(diethylamino)ethyl]ethanediamide | C14H30N4O2 | 5432-13-3 | Details |
2-(1H-1,2,3,4-Tetrazol-1-yl)ethane-1-sulfonamide | C3H7N5O2S | 1697255-05-2 | Details |
SH3GL2 Blocking Peptide | Details |
5'-ODMT-thymidine 3'-Sp-oxazaphospholidine | Details |
2-(Bromomethyl)-1,7-dioxaspiro[4.4]nonane | C8H13BrO2 | 1849262-52-7 | Details |
2-[4-(Trifluoromethyl)benzoyl]aniline | C14H10F3NO | 790-10-3 | Details |
TNF Receptor Type I protein | Details |
H-AL^P^AP^IEK^-OH | Details |
N-(Piperidin-4-yl)-1-benzofuran-2-carboxamide hydrochloride | C14H17ClN2O2 | 150515-80-3 | Details |
2,3-Dihydro-1H-indole-6-sulfonamide | C8H10N2O2S | 3074-25-7 | Details |
Methyl 3-amino-2-chlorobenzoate hydrochloride | C8H9Cl2NO2 | 53553-15-4 | Details |
4-Methylcycloheptane-1-carbonitriles | 1493160-84-1 | Details |
2-[1-(4-Fluorophenyl)-N-methylformamido]acetic acid | C10H10FNO3 | 133604-67-8 | Details |
2-(4,5-Dimethoxy-2-(thiomorpholin-4-ylsulfonyl)phenyl)acetic acid | C14H19NO6S2 | 1797096-12-8 | Details |
(E)-3-(5-Nitrothiophen-2-yl)acrylic acid | C7H5NO4S | 50868-70-7 | Details |
4-Chloro-3-[(2-methoxy-5-nitrophenyl)sulfamoyl]benzoic acid | C14H11ClN2O7S | 327092-59-1 | Details |
H-Ser-Met-OH | C8H16N2O4S | 3227-09-6 | Details |
Methyl 3-amino-3-cyclopropyl-2,2-dimethylpropanoate hydrochloride | 1350712-44-5 | Details |
2,2-dimethyl-3-(methylsulfanyl)propanoic acid | C6H12O2S | 37695-38-8 | Details |
Product Total: Product Page: | ||||
204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 |